Influence of Perioperative Kidney Function on Postoperative Outcome (NEPHRANEST)

October 8, 2012 updated by: Claudia Spies, Charite University, Berlin, Germany

Retrospective Data Analysis of the Impact of Perioperative Kidney Function on Postoperative Outcome

This study investigates the influence of perioperative changes in serum creatinine on hospital length of stay and mortality.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

39369

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
      • Berlin, Germany, 13353
        • Charité - University Medicine Berlin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Retrsospective analysis of electronic charts of all patients that underwent anesthesia between January 2006 - June 2012 in the Department of Anesthesiology at the Charité - University Medicine Berlin, Campus Charité Mitte und Campus Virchow Klinikum.

Description

Inclusion Criteria:

  • all patients anesthetized between January 2006 - June 2012

Exclusion Criteria:

  • end stage renal disease
  • pre-anesthesiologic need of renal replacement therapy
  • patients undergoing nephrectomy or kidney transplantation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients
Data of patients anesthetized in the years 2006 to 2012 (Hospital stay: January 2006 - June 2012) will be analysed in the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hospital length of stay
Time Frame: 1 year
once per case
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
all cause in-hospital mortality
Time Frame: 1 year
occurrence during hospital stay
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Charite University, Berlin, Germany

Investigators

  • Principal Investigator: Claudia D Spies, MD Prof., Charite University, Berlin, Germany

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2006

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

January 23, 2012

First Submitted That Met QC Criteria

January 27, 2012

First Posted (Estimate)

January 31, 2012

Study Record Updates

Last Update Posted (Estimate)

October 10, 2012

Last Update Submitted That Met QC Criteria

October 8, 2012

Last Verified

October 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NEPHRANEST

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Insufficiency

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe